Close
Home
Archive - August 2020
ADC Weekly Digest - 01 to 05 July 2024
ADC Weekly Digest - 03 to 05 July 20241
Clinical
Tisotumab Vedotin demonstrates superior survival outcomes in Advanced Cervical Cancer
5 July 2024
Commercial
Eisai Announces independent development and commercialization of Farletuzumab Ecteribulin (FZEC) Antibody Drug Conjugate (ADC)
5 July 2024
Patent
Daiichi Sankyo secures $47M in ADC Patent arbitration against Seagen, faces upcoming conflict with Pfizer
5 July 2024